We are seeking 40 participants to partake in a study of our healthy aging product, Qualia Senolytic. The product is formulated to help the body eliminate the stressed cells that accumulate with aging (i.e., senescent or zombie cells). You can find out more about Qualia Senolytic and its ingredients in our blog The Formulator's View of the Qualia Senolytic Ingredients.
This is a 7-day open-label study, meaning you will know that you are taking the Qualia Senolytic product. Participants will take six capsules per day for two days, followed by five days without supplementation. Upon completing the study, all participants will receive a $300 credit at Neurohacker.
Inflammatory biomarker levels will be measured at the beginning and end of the study using a self-administered blood drop collection kit. This kit requires participants to draw blood drops from their finger using a fingerstick. Additional information will be collected through self-report questionnaires, which should take approximately 15 minutes to complete at each assessment. Participants will also complete a self-reported diary, answering questions about adherence and any noticeable side effects.
Participation Requirements:
Healthy adults 45 β 79 years of age
Can read and write English
Agree to provide a valid cell phone number and are willing to receive communications through text
Willing to not begin taking any new supplements during the study and continue taking any supplements they are currently using regularly.
Willingness to complete questionnaires, records, and diaries associated with the study.
Exclusion Criteria:
Women who are pregnant, breastfeeding or planning to become pregnant during the trial
Known food intolerances/allergy to any ingredients in the product
Having any of the following conditions: Psychiatric conditions, neurologic disorders, high blood pressure, heart conditions, endocrine disorders, cancer
Taking MAO inhibitors, SSRIs, or any other psychiatric or neurological medicines
On immunosuppressive therapy